NCT06082063

N/AInterventional

Trials without FDA-defined phases, including trials of devices or behavioral interventions.

View on ClinicalTrials.gov ↗

Timeline

Start date: Feb 1, 2024
Primary completion: Feb 1, 2029
Completion date: Jan 1, 2030
First posted: Oct 13, 2023
Last posted: Oct 13, 2023
Enrollment: 2000
Arms / groups: 2 / —
Source: AACT · ctgov ingestion

Sponsors

Steno Diabetes Center CopenhagenLead sponsor
Aarhus UniversityCollaborator
University of CopenhagenCollaborator
Herning HospitalCollaborator
University of CopenhagenCollaborator
Hospital of South West JutlandCollaborator
University of CopenhagenCollaborator
Randers Regional HospitalCollaborator
Regionshospitalet HorsensCollaborator
Hospitalsenhed MidtCollaborator
Hospitalsenhed MidtCollaborator
University of CopenhagenCollaborator
University of Southern DenmarkCollaborator
Steno Diabetes Center CopenhagenOverall official - principal investigator
Steno Diabetes Center CopenhagenCollaborator
Odense University HospitalCollaborator
University of CopenhagenCollaborator
Steno Diabetes Center CopenhagenOfficial

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.